In both FAP and CRC patients, increased numbers of CD4+Foxp3+ Tregs have been shown in tumor-draining lymph nodes and tumor sites; the function of Treg cells remains controversial in both FAP and CRC (93). This evidence concerns the gene CD4 and colorectal carcinoma.